>_ Skip to main content
Menu
Search
Quantum Industry

IBM Completes Acquisition of Quantum Research Lab HRL


IBM has finalized its acquisition of HRL Laboratories, a Malibu-based research facility known for its work in silicon-spin qubits, quantum sensing, and cryogenics. Though the press release didn’t disclose financial terms of the deal, this acquisition is complete, and most of its anticipated benefits lie in the future.

Acquisition details

Previously, HRL was under joint ownership of Boeing and General Motors. The lab specializes in developing silicon heterostructure quantum-dot qubits, photonics, single-photon detectors, and chip-scale atom optics, according to its profile. Its quantum chip, SLEDGE, is accessible to researchers through the LPS Qubit Collaboratory. IBM views this acquisition as complementary, aligning HRL’s silicon-spin capabilities with its existing work in superconducting quantum technology.

IBM also highlights HRL’s contributions to its hardware program, including expertise in cryogenics, control electronics, packaging, and interconnect technologies. Boeing and GM will continue their collaboration with IBM and HRL on quantum applications and advanced technology development, as stated in the August 26 announcement

IBM’s future roadmap

The majority of IBM’s announcement focuses on future plans. The company reiterated its roadmap for Starling, a fault-tolerant machine projected for 2029, designed to perform 100 million quantum operations, followed by Blue Jay in the mid-2030s. These are roadmap targets, and their realization depends on IBM achieving error-correction progress at a scale not yet demonstrated. IBM’s current systems utilize superconducting qubits, and the addition of a silicon-spin lab doesn’t immediately alter its present qubit counts.

IBM also connected the acquisition to Anderon, its dedicated quantum wafer foundry, suggesting that HRL’s silicon expertise could support manufacturing efforts there. The most concrete detail in the release, despite its lack of specifics, is the completion of the acquisition at an undisclosed price.

Presently, readers should note that IBM now owns a well-equipped semiconductor lab it previously did not, and any significant returns on this investment are projected on a timeline measured in years by the company itself.